Results 31 to 40 of about 1,633 (196)

Consensus statement on safety measures for pressurized intraperitoneal aerosol chemotherapy

, 2021
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a promising treatment for peritoneal cancer that entails, however, potential risks for the caregivers in the operating room (OR). This study aimed to reach a consensus within the PIPAC community
Sgarbura, O., Reymond, M.A., Clerc, D., Hübner, M., Girardot-Miglierina, A., Villeneuve, L., Alyami, M., Daniel Clerc, Laurent Villeneuve, Villeneuve Laurent, Mohammad Alyami, Martin Hübner, Alyami Mohammad, Clerc Daniel, Arnaud Girardot-Miglierina, Olivia Sgarbura, Marc-André Reymond, Sgarbura Olivia, Reymond Marc-André, Hübner Martin, Girardot-Miglierina Arnaud   +20 more
core   +1 more source

The ISSPP PIPAC database: design, process, access, and first interim analysis [PDF]

Pleura and Peritoneum, 2021
Abstract Objectives Several trials have documented the favorable safety profile, and promising clinical results of pressurized intraperitoneal aerosol chemotherapy (PIPAC) directed treatment in different types of peritoneal malignancies.
Mortensen, Michael Bau, Glehen, Olivier, Horvath, Philipp, Hübner, Martin, Hyung-Ho, Kim, Königsrainer, Alfred, Pocard, Marc, Reymond, Marc Andre, So, Jimmy, Fristrup, Claus Wilki, Mortensen, Michael, Reymond, Marc, Fristrup, Claus   +12 more
openaire   +7 more sources

Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease

Journal of Surgical Oncology, Volume 125, Issue 7, Page 1176-1182, June 2022., 2022
Abstract Gastric cancer (GC) is an aggressive malignancy with a high burden of peritoneal disease. Evidence regarding the use of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) to improve outcomes has been growing.
Hamza Khan, Fabian M. Johnston
wiley   +1 more source

Unresectable colorectal peritoneal metastases:Exploring the role of PIPAC

, 2022
This thesis provided an overview of the incidence, treatment, and prognosis of colorectal peritoneal metastases and focused on the potential role of treatment with PIPAC in the palliative setting.
Lurvink, Robin, Robin Lurvink
core   +1 more source

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer

BMC Cancer, 2020
Background Peritoneal metastasis (PM) in patients with breast (BC) and endometrial cancer (EC) is rare and treatment options are limited. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) has demonstrated efficacy against PM from various cancers ...
Günther A. Rezniczek, Urs Giger-Pabst, Omar Thaher, Clemens B. Tempfer   +3 more
doaj   +1 more source

Establishment of a new valid animal model for the evaluation of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric rhabdomyosarcoma

Pediatric Blood &Cancer, Volume 68, Issue 11, November 2021., 2021
Abstract Background Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy has been established as a novel treatment approach for peritoneal sarcomatosis. Despite promising clinical reports, there is still a lack of knowledge regarding optimal drug usage and local effects. Therefore, we intended to establish a murine animal
Benedikt R. Wagner, Anna L. Adamus, Dörthe Sönnecken, Reza Vahdad, Paul Jank, Carsten Denkert, Andreas H. Mahnken, Guido Seitz   +7 more
wiley   +1 more source

Number of PIPAC per patient.

, 2023
To improve the prognosis and maintain quality of life in patients with peritoneal metastasis (PM), a novel treatment has been introduced–pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Pierre-Louis Conan (17511346), Adeline Aime (17511349), Hugo Picchi (17511355), Solène Doat (15006081), Marc Pocard (3795094), Jade Fawaz (17511352), Brice Malgras (17511343), Anne-Cécile Ezanno (17511340)   +7 more
core   +1 more source

Reasons for stopping PIPAC.

, 2023
* PIPAC = Pressurized IntraPeritoneal Aerosol Chemotherapy. CRS/HIPEC = CytoReductive Surgery/Hyperthermic IntraPeritoneal Chemotherapy.
Pierre-Louis Conan (17511346), Adeline Aime (17511349), Hugo Picchi (17511355), Solène Doat (15006081), Marc Pocard (3795094), Jade Fawaz (17511352), Brice Malgras (17511343), Anne-Cécile Ezanno (17511340)   +7 more
core   +1 more source

Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid

The Journal of Pathology: Clinical Research, Volume 7, Issue 3, Page 203-208, May 2021., 2021
Abstract Tumor‐derived cell‐free DNA (cfDNA) is an emerging biomarker for guiding the personalized treatment of patients with metastatic colorectal cancer (CRC). While patients with CRC liver metastases (CRC‐LM) have relatively high levels of plasma cfDNA, little is known about patients with CRC peritoneal metastases (CRC‐PM).
Iris van't Erve, Koen P Rovers, Alexander Constantinides, Karen Bolhuis, Emma CE Wassenaar, Robin J Lurvink, Clément J Huysentruyt, Petur Snaebjornsson, Djamila Boerma, Daan van den Broek, Tineke E Buffart, Max J Lahaye, Arend GJ Aalbers, Niels FM Kok, Gerrit A Meijer, Cornelis JA Punt, Onno Kranenburg, Ignace HJT de Hingh, Remond JA Fijneman   +18 more
wiley   +1 more source

Early postoperative outcomes of staging laparoscopy for peritoneal metastases with or without pressurized intra-peritoneal aerosol chemotherapy (PIPAC)

BMC Surgery, 2022
Background Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced for palliative treatment of peritoneal surface malignancies (PSM) and is currently tested also in the neoadjuvant and prophylactic setting.
Hugo Teixeira Farinha, Daphné Mattille, Styliani Mantziari, Nicolas Demartines, Martin Hübner   +4 more
doaj   +1 more source